Prognia
Drug Database
🇪🇺EU · EMARefusedATC: L01BA05Orphan Medicine

Folotyn(pralatrexate)

Lymphoma, T-Cell

Marketing Authorisation Holder: Allos Therapeutics Ltd

INN: pralatrexate

Indication

treatment of peripheral T-cell lymphoma

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Folotyn — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.